(SRPT) Sarepta Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Sarepta Therapeutics | (SRPT) share price targets
Complete technical analysis of Sarepta Therapeutics (SRPT) by charts plus indicators, forecast predictions and share price targets for Sarepta Therapeutics (SRPT)
Sarepta Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-07 View latest technical analysis
10 day averaged volume of Sarepta Therapeutics is 1168161
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Fri Mar 2025 | 103.03 | 104.02 | 104.85 | 102.00 | 0.993 times |
| 06 Thu Mar 2025 | 105.56 | 106.79 | 107.23 | 104.39 | 0.761 times |
| 05 Wed Mar 2025 | 107.67 | 102.94 | 107.77 | 102.94 | 1.518 times |
| 04 Tue Mar 2025 | 102.86 | 100.25 | 103.59 | 99.50 | 1.025 times |
| 03 Mon Mar 2025 | 101.22 | 106.75 | 107.35 | 100.14 | 1.16 times |
| 28 Fri Feb 2025 | 106.75 | 104.21 | 108.48 | 103.46 | 1.096 times |
| 27 Thu Feb 2025 | 103.06 | 101.00 | 109.50 | 101.00 | 1.361 times |
| 26 Wed Feb 2025 | 106.86 | 106.88 | 109.55 | 106.37 | 0.923 times |
| 25 Tue Feb 2025 | 106.95 | 105.75 | 107.11 | 103.33 | 0.916 times |
| 24 Mon Feb 2025 | 105.56 | 105.49 | 107.54 | 105.47 | 0.635 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 104, but if it comes above 104, then a intra day buy could be more profitable.
If you take a sell trade below 104, then use 104 as stoploss and 100.5 as target. However if you take a buy trade in stock , then use 104 as stoploss and 106.91 as target.
Share price targets for Sarepta Therapeutics (SRPT)
| Target Type | Value |
| Downside Target | 99.50 |
| Upside Target | 107.61 |
| Upside Target | 110.00 |
| Upside Target | 112.78 |
| Upside Target | 114.41 |
| Upside Target | 117.45 |
| Upside Target | 120.05 |
| Upside Target | 129.84 |
| Upside Target | 131.31 |
| Upside Target | 133.00 |
Intraday share price targets for Sarepta Therapeutics (SRPT)
| Target Type | Value |
| Downside Intraday Target | 99.1 |
| Downside Intraday Target | 95.16 |
| Upside Intraday Target | 107.37 |
| Upside Intraday Target | 111.7 |
| Upside Intraday Target | 103.43 |
Weekly technical analysis of Sarepta Therapeutics (SRPT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Fri Mar 2025 | 103.03 | 106.75 | 107.77 | 99.50 | 1.107 times |
| 28 Fri Feb 2025 | 106.75 | 105.49 | 109.55 | 101.00 | 1.615 times |
| 21 Fri Feb 2025 | 106.28 | 102.60 | 110.00 | 101.15 | 1.1 times |
| 14 Fri Feb 2025 | 107.95 | 112.00 | 114.41 | 107.61 | 0.858 times |
| 07 Fri Feb 2025 | 111.82 | 111.48 | 120.05 | 109.52 | 0.844 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Sarepta Therapeutics (SRPT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Fri Mar 2025 | 103.03 | 106.75 | 107.77 | 99.50 | 0.39 times |
| 28 Fri Feb 2025 | 106.75 | 111.48 | 120.05 | 101.00 | 0.889 times |
| 31 Fri Jan 2025 | 113.72 | 122.72 | 129.84 | 112.78 | 1.868 times |
| 31 Tue Dec 2024 | 121.59 | 128.36 | 131.31 | 117.45 | 0.351 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Sarepta Therapeutics (SRPT)
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Sarepta Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Sarepta Therapeutics in short term but the buy signal is initial and weak.
Sarepta Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sarepta Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sarepta Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 104.91 and Sarepta Therapeutics (SRPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sarepta Therapeutics (SRPT) stock. Volume based technical analysis of Sarepta Therapeutics (SRPT) stock is negative.
Sarepta Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Sarepta Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Sarepta Therapeutics in short term but the buy signal is initial and weak.
Sarepta Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sarepta Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sarepta Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 104.91 and Sarepta Therapeutics (SRPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sarepta Therapeutics (SRPT) stock. Volume based technical analysis of Sarepta Therapeutics (SRPT) stock is negative.
Sarepta Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.